痛风合并肥胖患者的减重治疗:一项概念验证随机试验
在丹麦开展的一项16周随机非盲平行组试验,将61例肥胖合并痛风患者按1:1随机分配至低能量饮食组(n=29)或对照饮食组(n=32),主要结局为体重变化。16周后,低能量饮食组体重变化为-15.4 kg,对照组为-7.7 kg,组间差异为-7.7 kg(95%CI -10.7至-4.7,P<0.001)。尽管结果可能有利于低能量饮食,但未能确认组间在血清尿酸水平变化和疲劳方面存在差异,疼痛和痛风发作也无组间差异。
要点
- 低能量饮食组16周体重变化-15.4 kg,对照组-7.7 kg,组间差异-7.7 kg(95%CI -10.7至-4.7,P<0.001)。
- 未能确认低能量饮食与对照饮食在血清尿酸水平变化和疲劳方面存在差异。
- 疼痛和痛风发作无组间差异,试验期间无严重不良事件或死亡发生。
核心结论
- 强化饮食干预在肥胖合并痛风患者中安全且有效降低体重,但减重并未直接转化为对血清尿酸水平、疲劳和疼痛的效应。
研究设计与样本
- 在丹麦开展的一项16周随机非盲平行组试验,将肥胖合并痛风个体按1:1随机分配至低能量饮食或对照饮食。
- 意向治疗人群共61例,低能量饮食组n=29,对照饮食组n=32;平均年龄60.3岁(SD 9.9),平均体重指数35.6(SD 5.0),59例(97%)为男性。
- 主要结局为体重变化,关键次要结局为血清尿酸水平变化及视觉模拟量表评估的疼痛和疲劳变化。
主要发现
- 16周后,低能量饮食组体重变化-15.4 kg vs 对照组-7.7 kg,组间差异-7.7 kg(95%CI -10.7至-4.7,P<0.001)。
- 尽管结果可能有利于低能量饮食,但未能确认组间在血清尿酸水平变化和疲劳方面存在差异。
- 疼痛和痛风发作无组间差异。
- 试验期间无严重不良事件或死亡发生。
关键数值与推荐
- 低能量饮食组体重变化-15.4 kg vs 对照组-7.7 kg,组间差异-7.7 kg(95%CI -10.7至-4.7,P<0.001)。
- 未能确认组间在血清尿酸水平变化和疲劳方面存在差异。
- 疼痛和痛风发作无组间差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Despite scarce evidence, guidelines recommend weight loss as a management strategy for patients with gout. We investigated the effect of an intensive dietary intervention on body weight and clinical measures of gout severity in individuals with obesity and gout. METHODS: We conducted a 16-week randomized nonmasked parallel-group trial in Denmark, randomly assigning (one-to-one) individuals with obesity and gout to a low-energy diet or a control diet. The primary outcome was change in body weight. Key secondary outcomes were changes in serum urate (SU) level and visual analog scale-assessed pain and fatigue. RESULTS: Between December 1, 2018, and June 1, 2019, 61 participants were included in the intention-to-treat population and randomly assigned to the intensive diet group (n = 29) or control diet group (n = 32). Participants had a mean age of 60.3 (SD 9.9) years and mean body mass index of 35.6 (SD 5.0), and 59 (97%) were men. After 16 weeks, there was a significant difference in change in body weight between the diet and control groups (-15.4 vs -7.7 kg; difference -7.7 kg [95% confidence interval -10.7 to -4.7], P < 0.001). Despite results being potentially in favor of a low-energy diet, we could not confirm differences in SU level changes and fatigue between groups. No differences in pain and gout flares were observed between groups. No serious adverse events or deaths occurred during the trial. CONCLUSION: An intensive dietary intervention was safe and effectively lowered body weight in people with obesity and gout, but the weight loss did not directly translate into effects on SU level, fatigue, and pain.
引用
- Christensen R, Zobbe K, Nielsen SM, et al. Weight Loss for Patients With Gout and Concomitant Obesity: A Proof-of-Concept Randomized Trial. Arthritis Rheumatol. 2024. PMID: 38169151. doi:10.1002/art.42790
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。